| Literature DB >> 33228329 |
Giuseppe Foti1,2, Alberto Giannini3, Nicola Bottino4, Gian Paolo Castelli5, Maurizio Cecconi6,7, Giacomo Grasselli4,8, Luca Guatteri9, Nicola Latronico3,10,11, Thomas Langer2,12, Giacomo Monti13, Stefano Muttini14, Antonio Pesenti4,8, Danilo Radrizzani15, Marco Ranucci16, Vincenzo Russotto17,2, Roberto Fumagalli2,12.
Abstract
With 63,098 confirmed cases on 17 April 2020 and 11,384 deaths, Lombardy has been the most affected region in Italy by coronavirus disease 2019 (COVID-19). To cope with this emergency, the COVID-19 Lombardy intensive care units (ICU) network was created. The network identified the need of defining a list of clinical recommendations to standardize treatment of patients with COVID-19 admitted to Intensive Care Unit (ICU). Three core topics were identified: 1) rational use of intensive care resources; 2) ventilation strategies; 3) non-ventilatory interventions. Identification of patients who may benefit from ICU treatment is challenging. Clinicians should consider baseline performance and frailty status and they should adopt disease-specific staging tools. Continuous positive airway pressure, mainly delivered through a helmet as elective method, should be considered as initial treatment for all patients with respiratory failure associated with COVID-19. In case of persisting dyspnea and/or desaturation despite 4-6 hours of noninvasive ventilation, endotracheal intubation and invasive mechanical ventilation should be considered. In the early phase, muscle relaxant use and volume-controlled ventilation is recommended. Prone position should be performed in patients with PaO<inf>2</inf>/FiO<inf>2</inf>≤100 mmHg. For patients admitted to ICU with COVID-19 interstitial pneumonia, we do not recommend empiric antibiotic therapy for community-acquired pneumonia. Consultation of an infectious disease specialist is suggested before start of any antiviral therapy. In conclusion, the COVID-19 Lombardy ICU Network identified a list of best practice statements supported by the available evidence and clinical experience or identified as panel members expert opinions for the management of critically ill patients with COVID-19.Entities:
Mesh:
Year: 2020 PMID: 33228329 DOI: 10.23736/S0375-9393.20.14762-X
Source DB: PubMed Journal: Minerva Anestesiol ISSN: 0375-9393 Impact factor: 3.051